Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 35,388 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: alone Clear all

Conditions: Duchenne Muscular Dystrophy
Interventions: Exercising, Optical and Magnetic Resonance Imaging and Spectroscopy; Other · Procedure
Lead sponsor: University of Florida; Other
Eligibility: 10 Years to 55 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: ESRD
Interventions: Sodium Restriction; Dietary Supplement
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COVID-19
Interventions: Facilitated Self-Sampling Intervention (FSSI), Testing Navigation Intervention (TNI)., Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 1,232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Brownsville, Texas • Houston, Texas • Tyler, Texas

Conditions: HIV, Substance Use
Interventions: Alcohol Use BI, Nutrition Intervention; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 16 Years to 25 Years
Enrollment: 464 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Dialysis Access Malfunction
Interventions: Angiography with IVUS; Device
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 4
States / cities: Dallas, Texas • Plano, Texas

Conditions: Healthy
Interventions: Imatinib Mesylate, Omeprazole; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoarthritis, Knee, Microfragmented Adipose Tissue, Platelet-Rich Plasma
Interventions: Platelet Rich Plasma; Device
Lead sponsor: Ohio State University; Other
Eligibility: 25 Years to 75 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Quality of Health Care, Patient Safety, Clinical Decision Support
Interventions: CITE evidence-grounding retrieve-and-verify layer, AI care plan with safety guardrails; Other
Lead sponsor: Waymark; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Respiratory Syncytial Virus (RSV)
Interventions: Investigational RSV vaccine MV-012-968 (Dosage 1), Investigational RSV vaccine MV-012-968 (Dosage 2), Investigational RSV vaccine MV-012-968 (Dosage 3; single-dose), Investigational RSV vaccine MV-012-968 (Dosage 3; two-dose), Placebo (single-dose), Placebo (two-dose); Biological · Other
Lead sponsor: Meissa Vaccines, Inc.; Industry
Eligibility: 6 Months to 36 Months
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 12
States / cities: Phoenix, Arizona • La Mesa, California • Atlanta, Georgia + 9 more

Conditions: Insomnia, Shift-Work Related Sleep Disturbance
Interventions: Cognitive Behavioral Therapy for Insomnia for Firefighters (CBT-I-F), Fitbit Inspire HR Wrist Worn Device (NCT04176926); Behavioral · Device
Lead sponsor: Pacific University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Forest Grove, Oregon

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Cisplatin, Gemcitabine, PF-3512676, Gemcitabine + Cisplatin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 839 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 10
States / cities: Birmingham, Alabama • Bakersfield, California • Saint Joseph, Michigan + 4 more

Conditions: Stage IV Uveal Melanoma
Interventions: Sir-Spheres®; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: NASH - Nonalcoholic Steatohepatitis
Interventions: BIO89-100; Drug
Lead sponsor: 89bio, Inc.; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Geographic Atrophy
Interventions: OpRegen; Biological
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 15
States / cities: Beverly Hills, California • Sacramento, California • San Francisco, California + 12 more

Conditions: Type 2 Diabetes Mellitus
Interventions: GSK376501, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Healthy
Interventions: IW-1973, Itraconazole; Drug
Lead sponsor: Cyclerion Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Hypovolemia, Craniosynostoses
Interventions: CardioQ-EDM and CipherOx-CRI; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 3 Months to 2 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Multiple Myeloma, Relapse, Refractory, Aging, Co-morbidity
Interventions: Isatuximab, Pomalidomide, Dexamethasone; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Dry Eye
Interventions: Lifitegrast 5% Ophthalmic Solution; Drug
Lead sponsor: Bucci Laser Vision Institute; Other
Eligibility: 60 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Wilkes-Barre, Pennsylvania

Conditions: Insulin Resistance
Interventions: Water-only Fasting; Other
Lead sponsor: TrueNorth Health Foundation; Other
Eligibility: 40 Years to 70 Years
Enrollment: 48 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: Alcohol Drinking, Anxiety Disorders
Interventions: Anxiety Attention Training, Alcohol Attention Training, Control Training; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Healthy
Interventions: Sodium ST20; Drug
Lead sponsor: HemaQuest Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Jejunostomy; Complications, Enteral and Supplement Feeds Adverse Reaction, Safety Issues
Interventions: Percutaneous Ultrasound Jejunostomy; Device
Lead sponsor: CoapTech; Industry
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: Focus of Attention; Other
Lead sponsor: Western Carolina University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cullowhee, North Carolina

Search by objective public record fields.

Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle

Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

Employing eSBI in HIV Testing for At-risk Youth

Trial Comparing Angiography and Angiography With IVUS for Treatment of Hemodialysis Access Failures

Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial

CITE: Clinical Inference Tethered to Evidence - a Retrieve-and-verify Layer for AI Care Plans

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

A Pilot Study of Cognitive Behavioral Therapy - Insomnia (CBT-I) Among Professional Firefighters

Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers

Bedside Resources to Gauge Intravascular Volume Status

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

Fasting for Brain and Heart Health (FBHH)

Retraining Attention to Treat Alcohol Dependence and Social Anxiety

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers

Clinical Pilot Study of the Percutaneous Ultrasound Jejunostomy Procedure

FOA on Sit to Stand in Individuals Post Chronic Stroke